Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells
NCT01575470Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Mar 2012
- Primary completion
- May 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived mononuclear cell in traumatic brain injury (TBI), sponsored by UTHealth Houston. Started Mar 2012; status: completed.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT01575470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01575470.